ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
129.922,38
0,69%
S&P 500
6.021,63
0,57%
US Dollar vs BRL
5,8119
0,01%
Bitcoin
93.163,60
1,30%
Brent Oil
72,335
-0,16%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) Notícias

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRIB
DataHoraFonteTítuloCódigoCompanhia
15/11/202419:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
15/11/202415:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
15/11/202411:00GlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
14/11/202419:26Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
07/11/202410:19GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
25/10/202409:45GlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
25/10/202409:45GlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
07/10/202409:15GlobeNewswire Inc.Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
24/09/202417:05GlobeNewswire Inc.Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketNASDAQ:TRIBTrinity Biotech PLC
20/09/202418:14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
18/09/202417:05GlobeNewswire Inc.Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerNASDAQ:TRIBTrinity Biotech PLC
09/09/202417:05GlobeNewswire Inc.Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
03/09/202410:55GlobeNewswire Inc.Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerNASDAQ:TRIBTrinity Biotech PLC
26/08/202417:05GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 SalesNASDAQ:TRIBTrinity Biotech PLC
20/08/202418:00GlobeNewswire Inc.Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing DirectorNASDAQ:TRIBTrinity Biotech PLC
14/08/202408:30GlobeNewswire Inc.Trinity Biotech Announces Q2 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
13/08/202417:05GlobeNewswire Inc.Trinity Biotech to Announce Q2 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
06/08/202417:05GlobeNewswire Inc.Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
02/08/202410:24GlobeNewswire Inc.Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScienceNASDAQ:TRIBTrinity Biotech PLC
12/07/202417:07Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:TRIBTrinity Biotech PLC
09/07/202417:05GlobeNewswire Inc.Trinity Biotech Announces Appointment of A New CFONASDAQ:TRIBTrinity Biotech PLC
24/06/202408:00GlobeNewswire Inc.Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM SensorNASDAQ:TRIBTrinity Biotech PLC
10/06/202410:10GlobeNewswire Inc.Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes AssociationNASDAQ:TRIBTrinity Biotech PLC
03/06/202405:00GlobeNewswire Inc.Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated TechnologyNASDAQ:TRIBTrinity Biotech PLC
23/05/202409:00GlobeNewswire Inc.Trinity Biotech Announces Q1 2024 Financial Results and Reiterates GuidanceNASDAQ:TRIBTrinity Biotech PLC
16/05/202410:18GlobeNewswire Inc.Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAINASDAQ:TRIBTrinity Biotech PLC
13/05/202412:42GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesNASDAQ:TRIBTrinity Biotech PLC
08/05/202411:36GlobeNewswire Inc.Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentNASDAQ:TRIBTrinity Biotech PLC
08/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
07/05/202417:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRIB

Seu Histórico Recente

LSE
ECEL
Eurocell
LSE
CMG
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 60%* para TRADER BRASIL

1 ano 40%, 2 anos 50% e *3 anos 60%

*Ao longo de 3 anos $ 881.64 apenas $ 352.65